Shinya Mikami

Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas

The Trk family of tyrosine protein kinase receptors plays a significant role in the development and maintenance of neural tissues. It has been recently shown that Trk receptors are also expressed by a wide range of normal non‐neuronal tissues in humans in a cell type‐specific manner. In the present study, the expression patterns of TrkA in 337 non‐neuronal invasive carcinomas of 15 different human tissues were investigated immunohistochemically. Overall, 133 (39%), 101 (30%) and 103 (31%) tumors exhibited strong, moderate and no TrkA Immunoreactivity, respectively. Esophageal and thyroid carcinomas expressed high levels of TrkA, whereas the levels in gastric and colon cancers were low. TrkA expression was detected not only in carcinomas originating from TrkA‐positive normal counterpart tissues, Including the esophagus, breast, lung and uterus, but also in those from TrkA‐negative tissues/cells of the thyroid, liver and ovary. Immunostaining for nerve growth factor‐β, the specific ligand for TrkA, in esophageal and breast carcinomas demonstrated its immunoreactivity in stromal fibroblasts and some TrkA‐expressing tumor cells. These results suggest that paracrine/autocrine regulation via stromal/tumoral NGF‐tumoral TrkA interaction may be involved In the growth of certain non‐neuronal carcinomas.